Omalizumab Treatment in Venom Immunotherapy With Systemic Reactions

NCT02968394 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Allergy
Bee Venom
Immunotherapy
Omalizumab

Interventions

DRUG: omalizumab

Sponsor

The University Clinic of Pulmonary and Allergic Diseases Golnik